Actelion Pharmaceuticals Ltd
Records under this name other than the patents Actelion Pharmaceuticals Ltd holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 27 patents it holds.
Back to Actelion Pharmaceuticals Ltd
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,763,638 | Substituted 1,2,3,4-Tetrahydroisoquinoline Derivatives now held by Idorsia Pharmaceuticals Ltd. In force · High confidence | In force | High confidence | |
| US 8,575,200 | PYRIDIN-2-YL Derivatives as Immunomodulating Agents now held by Viatris Asia Pacific Pte. Ltd. In force · High confidence | In force | High confidence | |
| US 8,580,824 | PYRIDIN-4-YL Derivatives as Immunomodulating Agents now held by Viatris Asia Pacific Pte. Ltd. In force · High confidence | In force | High confidence | |
| US 8,501,817 | Stabilized Compositions of Alkylating Agents and Methods of Using Same now held by Helsinn Birex Pharmaceuticals Limited In force · High confidence | In force | High confidence | |
| US 8,044,055 | 2-Phenyl-6-Aminocarbonyl-PYRIMIDINE Derivatives and Their Use as P2Y12 Receptor now held by Viatris Asia Pacific Pte. Ltd. In force · Medium confidence | In force | Medium confidence | |
| US 8,221,978 | Normalization Probes for Comparative Genome Hybridization Arrays now held by Agilent Technologies, Inc. In force · High confidence | In force | High confidence | |
| US 8,093,250 | 2-Aminocarbonyl-PYRIDINE Derivatives now held by Viatris Asia Pacific Pte. Ltd. In force · High confidence | In force | High confidence | |
| US 8,263,780 | New Process for the Preparation of 2-Imino-THIAZOLIDIN-4-ONE Derivatives now held by Vanda Pharmaceuticals Inc. In force · High confidence | In force | High confidence | |
| US 8,912,340 | New Process for the Preparation of 2-Imino-THIAZOLIDIN-4-ONE Derivatives now held by Vanda Pharmaceuticals Inc. In force · High confidence | In force | High confidence | |
| US 8,048,881 | Pyrimidine Derivatives and Their Use as P2Y12 Receptor Antagonists now held by Viatris Asia Pacific Pte. Ltd. In force · High confidence | In force | High confidence |